- Home
- MUR vs TFX Comparison
MUR vs TFX Comparison
Compare MUR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MUR | TFX |
|---|---|---|
| Founded | 1950 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.8B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MUR | TFX |
|---|---|---|
| Price | $35.22 | $126.88 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 8 |
| Target Price | $34.36 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.8M | 554.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.35% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $2,718,823,000.00 | $1,992,713,000.00 |
| Revenue This Year | $9.45 | $15.97 |
| Revenue Next Year | $3.94 | $5.15 |
| P/E Ratio | $97.35 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.86 | $100.18 |
| 52 Week High | $43.34 | $139.67 |
Technical Indicators
Market Signals| Indicator | MUR | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 47.81 |
| Support Level | $29.81 | $124.49 |
| Resistance Level | $36.08 | $135.55 |
| Average True Range (ATR) | 1.41 | 3.77 |
| MACD | -0.32 | -0.77 |
| Stochastic Oscillator | 21.61 | 38.02 |
Price Performance
Historical ComparisonAbout MUR Murphy Oil Corporation
Murphy Oil Corp is an oil and gas exploration and production company, with both onshore and offshore operations and properties. It operates in two geographic reportable segments the United States and Canada. It generates the majority of its revenue form the United States. The company also generates revenue from sales of oil and natural gas production activities.
About TFX Teleflex Incorporated
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.